Suppr超能文献

用于干眼症的泪点闭塞术。

Punctal occlusion for dry eye syndrome.

作者信息

Ervin Ann-Margret, Law Andrew, Pucker Andrew D

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, E6146, Baltimore, Maryland, USA, 21205.

出版信息

Cochrane Database Syst Rev. 2017 Jun 26;6(6):CD006775. doi: 10.1002/14651858.CD006775.pub3.

Abstract

BACKGROUND

Dry eye syndrome is a disorder of the tear film that is associated with symptoms of ocular discomfort. Punctal occlusion is a mechanical treatment that blocks the tear drainage system in order to aid in the preservation of natural tears on the ocular surface.

OBJECTIVES

To assess the effects of punctal plugs versus no punctal plugs, different types of punctal plugs, and other interventions for managing dry eye.

SEARCH METHODS

We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 11), MEDLINE Ovid (1946 to 8 December 2016), Embase.com (1947 to 8 December 2016), PubMed (1948 to 8 December 2016), LILACS (Latin American and Caribbean Health Sciences Literature Database) (1982 to 8 December 2016), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com; last searched 18 November 2012 - this resource is now archived), ClinicalTrials.gov (www.clinicaltrials.gov; searched 8 December 2016), and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en; searched 8 December 2016). We did not use any date or language restrictions in the electronic searches for trials. We also searched the Science Citation Index-Expanded database and reference lists of included studies. The evidence was last updated on 8 December 2016 SELECTION CRITERIA: We included randomized and quasi-randomized controlled trials of collagen or silicone punctal plugs in symptomatic participants diagnosed with aqueous tear deficiency or dry eye syndrome.

DATA COLLECTION AND ANALYSIS

Two review authors independently assessed trial quality and extracted data. We contacted study investigators for additional information when needed.

MAIN RESULTS

We included 18 trials (711 participants, 1249 eyes) from Austria, Canada, China, Greece, Japan, Mexico, Netherlands, Turkey, the UK, and the USA in this review. We also identified one ongoing trial. Overall we judged these trials to be at unclear risk of bias because they were poorly reported. We assessed the evidence for eight comparisons.Five trials compared punctal plugs with no punctal plugs (control). Three of these trials employed a sham treatment and two trials observed the control group. Two trials did not report outcome data relevant to this review. There was very low-certainty evidence on symptomatic improvement. The three trials that reported this outcome used different scales to measure symptoms. In all three trials, there was little or no improvement in symptom scores with punctal plugs compared with no punctal plugs. Low-certainty evidence from one trial suggested less ocular surface staining in the punctal plug group compared with the no punctal plug group however this difference was small and possibly clinically unimportant (mean difference (MD) in fluorescein staining score -1.50 points, 95% CI -1.88 to -1.12; eyes = 61). Similarly there was a small difference in tear film stability with people in the punctal plug group having more stability (MD 1.93 seconds more, 95% CI 0.67 to 3.20; eyes = 28, low-certainty evidence). The number of artificial tear applications was lower in the punctal plug group compared with the no punctal plugs group in one trial (MD -2.70 applications, 95% CI -3.11 to -2.29; eyes = 61, low-certainty evidence). One trial with low-certainty evidence reported little or no difference between the groups in Schirmer scores, but did not report any quantitative data on aqueous tear production. Very low-certainty evidence on adverse events suggested that events occurred reasonably frequently in the punctal plug group and included epiphora, itching, tenderness and swelling of lids with mucous discharge, and plug displacement.One trial compared punctal plugs with cyclosporine (20 eyes) and one trial compared punctal plugs with oral pilocarpine (55 eyes). The evidence was judged to be very low-certainty due to a combination of risk of bias and imprecision.Five trials compared punctal plugs with artificial tears. In one of the trials punctal plugs was combined with artificial tears and compared with artificial tears alone. There was very low-certainty evidence on symptomatic improvement. Low-certainty evidence of little or no improvement in ocular surface staining comparing punctal plugs with artificial tears (MD right eye 0.10 points higher, 0.56 lower to 0.76 higher, MD left eye 0.60 points higher, 0.10 to 1.10 higher) and low-certainty evidence of little or no difference in aqueous tear production (MD 0.00 mm/5 min, 0.33 lower to 0.33 higher)Three trials compared punctal plugs in the upper versus the lower puncta, and none of them reported the review outcomes at long-term follow-up. One trial with very low-certainty evidence reported no observed complications, but it was unclear which complications were collected.One trial compared acrylic punctal plugs with silicone punctal plugs and the trial reported outcomes at approximately 11 weeks of follow-up (36 eyes). The evidence was judged to be very low-certainty due to a combination of risk of bias and imprecision.One trial compared intracanalicular punctal plugs with silicone punctal plugs at three months follow-up (57 eyes). The evidence was judged to be very low-certainty due to a combination of risk of bias and imprecision.Finally, two trials with very low-certainty evidence compared collagen punctal plugs versus silicone punctal plugs (98 eyes). The evidence was judged to be very low-certainty due to a combination of risk of bias and imprecision.

AUTHORS' CONCLUSIONS: Although the investigators of the individual trials concluded that punctal plugs are an effective means for treating dry eye signs and symptoms, the evidence in this systematic review suggests that improvements in symptoms and commonly tested dry eye signs are inconclusive. Despite the inclusion of 11 additional trials, the findings of this updated review are consistent with the previous review published in 2010. The type of punctal plug investigated, the type and severity of dry eye being treated, and heterogeneity in trial methodology confounds our ability to make decisive statements regarding the effectiveness of punctal plug use. Although punctal plugs are believed to be relatively safe, their use is commonly associated with epiphora and, less commonly, with inflammatory conditions such as dacryocystitis.

摘要

背景

干眼综合征是一种泪膜紊乱疾病,伴有眼部不适症状。泪点阻塞是一种机械治疗方法,通过阻塞泪液引流系统,以帮助维持眼表的自然泪液。

目的

评估泪点塞与无泪点塞、不同类型泪点塞以及其他治疗干眼的干预措施的效果。

检索方法

我们检索了Cochrane对照试验中心注册库(CENTRAL)(其中包含Cochrane眼科和视力试验注册库)(2016年第11期)、MEDLINE Ovid(1946年至2016年12月8日)、Embase.com(1947年至2016年12月8日)、PubMed(1948年至2016年12月8日)、LILACS(拉丁美洲和加勒比健康科学文献数据库)(1982年至2016年12月8日)、对照试验元注册库(mRCT)(www.controlled-trials.com;最后检索时间为2012年11月18日 - 该资源现已存档)、ClinicalTrials.gov(www.clinicaltrials.gov;检索时间为2016年12月8日)以及世界卫生组织国际临床试验注册平台(ICTRP)(www.who.int/ictrp/search/en;检索时间为2016年12月8日)。在电子检索试验时,我们未使用任何日期或语言限制。我们还检索了科学引文索引扩展数据库以及纳入研究的参考文献列表。证据的最后更新时间为2016年12月8日。

入选标准

我们纳入了对诊断为水性泪液缺乏或干眼综合征的有症状参与者使用胶原蛋白或硅胶泪点塞的随机和半随机对照试验。

数据收集与分析

两位综述作者独立评估试验质量并提取数据。如有需要,我们会联系研究调查人员获取更多信息。

主要结果

我们在本综述中纳入了来自奥地利、加拿大、中国、希腊、日本、墨西哥、荷兰、土耳其、英国和美国的18项试验(711名参与者,1249只眼)。我们还识别出一项正在进行的试验。总体而言,我们认为这些试验存在不明确的偏倚风险,因为报告质量较差。我们评估了八项比较的证据。

五项试验比较了泪点塞与无泪点塞(对照)。其中三项试验采用了假治疗,两项试验观察了对照组。两项试验未报告与本综述相关的结局数据。关于症状改善的证据确定性极低。报告该结局的三项试验使用了不同的量表来测量症状。在所有三项试验中,与无泪点塞相比,使用泪点塞时症状评分几乎没有改善。一项试验的低确定性证据表明,与无泪点塞组相比,泪点塞组的眼表染色较少,然而这种差异很小且可能在临床上并不重要(荧光素染色评分的平均差(MD)为 -1.50分,95%可信区间为 -1.88至 -1.12;眼数 = 61)。同样,泪膜稳定性也存在微小差异,泪点塞组的稳定性更高(MD多1.93秒,95%可信区间为0.67至3.20;眼数 = 28,低确定性证据)。在一项试验中,泪点塞组的人工泪液使用次数低于无泪点塞组(MD -2.70次,95%可信区间为 -3.11至 -2.29;眼数 = 61,低确定性证据)。一项证据确定性低的数据表明,两组在Schirmer评分上几乎没有差异,但未报告任何关于水性泪液分泌的定量数据。关于不良事件的极低确定性证据表明,泪点塞组不良事件发生频率较高,包括溢泪、瘙痒、眼睑压痛和肿胀伴粘液分泌以及塞子移位。

一项试验比较了泪点塞与环孢素(20只眼),一项试验比较了泪点塞与口服毛果芸香碱(55只眼)。由于偏倚风险和不精确性的综合影响,证据被判定为极低确定性。

五项试验比较了泪点塞与人工泪液。其中一项试验将泪点塞与人工泪液联合使用,并与单独使用人工泪液进行比较。关于症状改善的证据确定性极低。泪点塞与人工泪液相比,眼表染色几乎没有改善的低确定性证据(右眼MD高0.10分,低0.56至高0.76分,左眼MD高0.60分,高0.10至1.10分)以及水性泪液分泌几乎没有差异的低确定性证据(MD 0.00 mm/5分钟,低0.33至高0.33分)。

三项试验比较了上泪点与下泪点使用泪点塞的情况,且均未报告长期随访的综述结局。一项证据确定性极低的试验报告未观察到并发症,但不清楚收集了哪些并发症。

一项试验比较了丙烯酸泪点塞与硅胶泪点塞,并在随访约11周时报告了结局(36只眼)。由于偏倚风险和不精确性的综合影响,证据被判定为极低确定性。

一项试验在随访三个月时比较了泪道内泪点塞与硅胶泪点塞(57只眼)。由于偏倚风险和不精确性的综合影响,证据被判定为极低确定性。

最后,两项证据确定性极低的试验比较了胶原蛋白泪点塞与硅胶泪点塞(98只眼)。由于偏倚风险和不精确性的综合影响,证据被判定为极低确定性。

作者结论

尽管各试验的研究者得出结论认为泪点塞是治疗干眼体征和症状的有效方法,但本系统综述中的证据表明,症状和常见干眼体征的改善尚无定论。尽管纳入了另外11项试验,但本次更新综述的结果与2010年发表的上一篇综述一致。所研究的泪点塞类型、所治疗干眼的类型和严重程度以及试验方法的异质性,使我们难以就泪点塞使用的有效性做出决定性陈述。尽管泪点塞被认为相对安全,但其使用通常与溢泪相关,较少与泪囊炎等炎症性疾病相关。

相似文献

1
Punctal occlusion for dry eye syndrome.
Cochrane Database Syst Rev. 2017 Jun 26;6(6):CD006775. doi: 10.1002/14651858.CD006775.pub3.
2
Autologous serum eye drops for dry eye.
Cochrane Database Syst Rev. 2017 Feb 28;2(2):CD009327. doi: 10.1002/14651858.CD009327.pub3.
3
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.
Cochrane Database Syst Rev. 2022 Mar 3;3(3):CD013520. doi: 10.1002/14651858.CD013520.pub2.
4
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.
Cochrane Database Syst Rev. 2017 Feb 22;2(2):CD012131. doi: 10.1002/14651858.CD012131.pub2.
5
Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD010516. doi: 10.1002/14651858.CD010516.pub2.
6
Topical corticosteroids for dry eye.
Cochrane Database Syst Rev. 2022 Oct 21;10(10):CD015070. doi: 10.1002/14651858.CD015070.pub2.
7
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2.
8
Aqueous shunts for glaucoma.
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD004918. doi: 10.1002/14651858.CD004918.pub3.
9
Interventions for eye movement disorders due to acquired brain injury.
Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD011290. doi: 10.1002/14651858.CD011290.pub2.
10
Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction.
Cochrane Database Syst Rev. 2017 Feb 24;2(2):CD007097. doi: 10.1002/14651858.CD007097.pub3.

引用本文的文献

2
Navigating the Dry Eye Therapeutic Puzzle: A Mechanism-Based Overview of Current Treatments.
Pharmaceuticals (Basel). 2025 Jul 2;18(7):994. doi: 10.3390/ph18070994.
4
Overview of Dry Eye Disease for Primary Care Physicians.
Medicina (Kaunas). 2025 Mar 6;61(3):460. doi: 10.3390/medicina61030460.
5
Seasonal variations and environmental influences on dry eye operations in Japan.
Sci Rep. 2024 Dec 28;14(1):30962. doi: 10.1038/s41598-024-82051-0.
6
Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals.
Pharmaceuticals (Basel). 2024 Oct 2;17(10):1315. doi: 10.3390/ph17101315.
7
Response predictors of a topical corticosteroid-based regimen for dry eyes: A real-life study.
Acta Ophthalmol. 2025 Feb;103(1):93-98. doi: 10.1111/aos.16758. Epub 2024 Sep 30.
8
Quintessence of currently approved and upcoming treatments for dry eye disease.
Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):269-278. doi: 10.1007/s00417-024-06587-7. Epub 2024 Aug 31.
9
Punctal cautery in dry eye disease: A systematic review.
Ocul Surf. 2024 Oct;34:235-240. doi: 10.1016/j.jtos.2024.08.006. Epub 2024 Aug 9.
10
Executive summary: British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.
Rheumatology (Oxford). 2025 Feb 1;64(2):396-408. doi: 10.1093/rheumatology/keae218.

本文引用的文献

1
Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease.
J Ophthalmol. 2016;2016:9312340. doi: 10.1155/2016/9312340. Epub 2016 Mar 7.
2
Over the counter (OTC) artificial tear drops for dry eye syndrome.
Cochrane Database Syst Rev. 2016 Feb 23;2(2):CD009729. doi: 10.1002/14651858.CD009729.pub2.
3
Safety and Efficacy of Lacrimal Drainage System Plugs for Dry Eye Syndrome: A Report by the American Academy of Ophthalmology.
Ophthalmology. 2015 Aug;122(8):1681-7. doi: 10.1016/j.ophtha.2015.04.034. Epub 2015 May 30.
4
Punctal Plug Retention Rates for the Treatment of Moderate to Severe Dry Eye: A Randomized, Double-Masked, Controlled Clinical Trial.
Am J Ophthalmol. 2015 Aug;160(2):238-242.e1. doi: 10.1016/j.ajo.2015.05.013. Epub 2015 May 18.
5
Punctal plug: a medical device to treat dry eye syndrome and for sustained drug delivery to the eye.
Drug Discov Today. 2015 Jul;20(7):884-9. doi: 10.1016/j.drudis.2015.01.013. Epub 2015 Feb 7.
6
Prospective evaluation of hypromellose 2% for punctal occlusion in patients with dry eye.
Cornea. 2015 Feb;34(2):188-92. doi: 10.1097/ICO.0000000000000325.
7
Botulinum neurotoxin type A versus punctal plug insertion in the management of dry eye disease.
Oman J Ophthalmol. 2014 May;7(2):61-5. doi: 10.4103/0974-620X.137142.
8
Punctal plugs versus artificial tears for treating dry eye: a comparative observation of their effects on contrast sensitivity.
J Ocul Biol Dis Infor. 2012 Nov 29;5(1):19-24. doi: 10.1007/s12177-012-9094-x. eCollection 2012.
9
Evaluation of a thermosensitive atelocollagen punctal plug treatment for dry eye disease.
Am J Ophthalmol. 2014 Feb;157(2):311-317.e1. doi: 10.1016/j.ajo.2013.10.019. Epub 2013 Nov 6.
10
Autologous serum eye drops for dry eye.
Cochrane Database Syst Rev. 2013 Aug 27;8(8):CD009327. doi: 10.1002/14651858.CD009327.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验